In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


National Consumers League supports Questran switch contingent on consumer education.

This article was originally published in The Tan Sheet

Executive Summary

NATIONAL CONSUMERS LEAGUE SUPPORT FOR QUESTRAN SWITCH CONTINGENT on "several levels of consumer education and information," NCL President Linda Golodner said at the May 13 FDA advisory committee meeting on the switch. She emphasized that "to educate the consumer about the safe and effective use of this medication as an OTC drug will take careful and continued reinforcement by health professionals and by the industry."





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts